NRDC v. Andrew Wheeler et al

October 3, 2017
Provisional judgment
United States, Washignton DC

Environmental NGOs
Natural Resources Defense Council
EPA, Andrew Wheeler
Jolie D. McLaughlin, Rebecca J. Riley, Daniel L. Raichel, Lucas J. Rhoads

Stipulated Settlement Agreement
Imidacloprid, Dinotefuran, Acetamiprid, Neonicotinoid, Insecticide
NRDC ask for EPA to take into account the effects of dangerous active ingredients on 95 products regarding the Endangered Species Act
United States District Court for the District of Columbia of Washignton DC, United States

January 15, 2021
Partially Positive
NRDC and EPA reached an agreement that requires EPA to begin evaluating the impacts of imidacloprid on endangered and threatened bees, butterflies, birds and other wildlife as required by the Endangered Species Act (ESA).
National law

Plaintiff files an action against EPA, alleging that it violated the Endangered Species Act (ESA), by failing to consult on the effects of 95 pesticide products registrations containing neonicotinoids: acetamiprid, dinotefuran, or imidacloprid, on Oct. 3, 2017. On Feb. 8, 2018, Parties entered into a Stipulation of Partial Dismissal of any and all claims related to 36 pesticide products. On January 15, 2021, Parties agreed to a partial settlement agreement which requires EPA to evaluate the impacts of imidacloprid and to meet to resolve the remaining issue on acetamiprid and dinotefuran.